Abstract
It has been showed that the introduction of nitrocompounds (as nitic oxide donors) in to the compositions of cyclophosphamide and hydroxamic acids for curing animals having leukemia P-388 increased duration of life by 290%. Thereby 40% of animals have recovered. The therapeutic dose cyclophosphamide have been reduced by 6 times.
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology*
-
Cyclophosphamide / pharmacology*
-
Drug Synergism
-
Female
-
Hydroxamic Acids / pharmacology*
-
Leukemia P388 / drug therapy*
-
Male
-
Mice
-
Nitrates / pharmacology*
-
Survival Analysis
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Hydroxamic Acids
-
Nitrates
-
sodium nitrate
-
Cyclophosphamide